SCHEMBL3714836

SCHEMBL3714836

CCC1CCc2ccccc2/C1=C/C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.41
HTR1A P08908 2/20 0.38
SIGMAR1 Q99720 2/20 0.38
ACHE P22303 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CAMK2A Q9UQM7 1/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
MITF O75030 1/20 0.36
HSP90AA1 P07900 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15520896 1.00 CYP19A1 (0.41) CYP19A1HTR1ASIGMAR1ACHECYP1A2
Pyruvate SCHEMBL7525474 0.74 CYP19A1 (0.53) CYP19A1HTR1ASIGMAR1ACHECYP1A2
SCHEMBL5608451 0.73 CYP19A1 (0.59) CYP19A1HTR1ASIGMAR1ACHECYP1A2
SCHEMBL11119074 0.68 RAB9A (0.49) HTR1ASIGMAR1CYP1A2CYP2D6CYP2C9
SCHEMBL8535642 0.67 CYP19A1 (0.58) CYP19A1HTR1ASIGMAR1ACHECYP1A2
SCHEMBL3697185 0.66 MAOB (0.50) CYP19A1MITFHSP90AA1RAB9AALDH1A1
SCHEMBL3697186 0.66 MAOB (0.50) CYP19A1MITFHSP90AA1RAB9AALDH1A1
SCHEMBL9179498 0.66 MAOB (0.50) CYP19A1MITFHSP90AA1RAB9AALDH1A1
SCHEMBL9115029 0.66 HTR6 (0.54) HTR1AACHEMTNR1AMTNR1B
SCHEMBL15700140 0.65 ACHE (0.56) CYP19A1HTR1ASIGMAR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398789-A1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck Sharp & Dohme Corp. (US) 2011-12-28 EP disclosed
WO-2010094242-A1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME CORP. (US) 2010-08-26 WO disclosed